Health
Study reports promising new monoclonal antibody against SARS-CoV-2’s spike protein – News-Medical.Net
An encouraging new study describes a promising new therapeutic antibody that shows potent neutralizing activity against SARS-CoV-2, the causative agent of COVID-19….
As the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), refuses to subside, the search for effective antivirals and therapeutics continues without respite. An encouraging paper published in the journal Nature Communicationson January 12, 2021, describes a promising new therapeutic antibody that potently neutralizes the virus.
SARS-CoV-2 has its own spike protein that interacts with the human angiotensin-converting enzyme 2 (ACE2)…
-
Noosa News19 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business23 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business22 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News19 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites